Develops treatments for gastrointestinal diseases and disorders, focusing on improving patient outcomes through innovative drug formulations.
Evoke Pharma, Inc. is a specialty pharmaceutical company specializing in the advancement and commercialization of treatments for gastroenterological disorders. At the forefront of its pipeline is Gimoti, a metoclopramide nasal spray that has successfully completed Phase 3 clinical trials. This innovative product targets symptoms associated with acute and recurrent diabetic gastroparesis specifically in females, addressing a significant unmet medical need in the field.
The company strategically markets its products to a diverse range of healthcare professionals including gastroenterologists, internal medicine specialists, primary care physicians, and selected healthcare providers.a. This targeted approach ensures that Evoke Pharma effectively reaches key decision-makers in the medical community, facilitating broader adoption and accessibility of its therapeutic solutions.
Established in 2007 and headquartered in Solana Beach, California, Evoke Pharma continues to expand its footprint in the pharmaceutical industry. With a dedicated focus on gastroenterological treatments and a commitment to clinical advancement, the company remains poised to deliver impactful therapies that improve patient outcomes and quality of life.